Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Astrazeneca Plc Ord (OP: AZNCF ) 156.38 -3.86 (-2.41%) Streaming Delayed Price Updated: 2:28 PM EDT, Sep 12, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Astrazeneca Plc Ord < Previous 1 2 3 4 5 6 7 8 Next > Schrodinger is an AI-Powered Drug Discovery Developer to Watch March 08, 2023 Drug discovery software developer Schrodinger Inc. (NASDAQ: SDGR) stock has been trying to recover after plummeting over 80% off its all-time high of $117 Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety AstraZeneca-Daiichi Sankyo's Flagship Cancer Drug Shows Meaningful, Durable Responses In Other Solid Tumor Setting March 06, 2023 Via Benzinga AstraZeneca Forecasts Growth In 2023 Earnings, Revenue Despite Fall In COVID-19 Products, Plans To Deliver 15 New Medicines This Decade February 09, 2023 Via Benzinga AstraZeneca's New Asthma Treatment for Adults Gets Green Light from FDA January 11, 2023 Via Benzinga AstraZeneca's Imfinzi Combo Scores FDA Approval For Liver Cancer October 24, 2022 Via Benzinga Japan Approves AstraZeneca's Two Treatments For Asthma, Rare Form Of Cancer September 27, 2022 Via Benzinga AstraZeneca To Acquire CinCor Pharma To Strengthen Cardiorenal Pipeline January 09, 2023 Via Benzinga AstraZeneca's Current Valuation Not Reflective Of Its Strong Fundamentals, Analyst Says January 05, 2023 Via Benzinga Europe Approves AstraZeneca's Two Combo Therapies For Prostate, Bile Duct Cancer Settings December 21, 2022 Via Benzinga AstraZeneca - Daiichi Sankyo's Enhertu Wins European Approval For Gastric Cancer, CHMP Backs Other Cancer Drugs December 19, 2022 Via Benzinga AstraZeneca Drug Imfinzi Fails As Monotherapy In Metastatic Lung Cancer Setting December 19, 2022 Via Benzinga FDA Extends Review Period For AstraZeneca-Merck Partnered Cancer Drug, Lynparza December 15, 2022 Via Benzinga AstraZeneca Highlights First Results From Datopotamab Study In Pretreated Breast Cancer Patients December 09, 2022 Via Benzinga AstraZeneca Highlights Detailed Data From Two Breast Cancer Trials December 08, 2022 Via Benzinga AstraZeneca's Enhertu Cuts Risk Of Death By 36% VsTrastuzumab In Metastatic Breast Cancer December 07, 2022 Via Benzinga AstraZeneca Bets On UK Listed Firm For Lung Diseases November 28, 2022 Via Benzinga Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says November 16, 2022 Via Benzinga European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs November 14, 2022 Via Benzinga FDA Approves AstraZeneca's Imfinzi/Imjudo Chemo Combo For Late Stage Lung Cancer November 11, 2022 Via Benzinga AstraZeneca Ditches US Application Submission For COVID-19 Shot, Q3 Edges Analyst Expectations On Oncology Strength November 10, 2022 Via Benzinga FDA Adcomm Backs AstraZeneca's 2-In-1 Asthma Inhaler, Only For Adults Being Less Sure For Adolescents, Kids November 09, 2022 Via Benzinga Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants November 04, 2022 Via Benzinga European Regulator Grants Complete Approval To AstraZeneca's COVID-19 Vaccine November 01, 2022 Via Benzinga AstraZeneca's Ultomiris Showed Zero Relapses In Patients With Chronic Disorder Of Brain, Spinal Cord October 27, 2022 Via Benzinga AstraZeneca Touts Positive Data From Two Experimental Drugs In Breast Cancer Settings October 26, 2022 Via Benzinga AstraZeneca's Fasenra Flunks Late-Stage Trial In Patients With Esophagus Inflammation October 25, 2022 Via Benzinga Illumina Inks AI Pact With AstraZeneca To Accelerate Drug Target Discovery October 11, 2022 Via Benzinga AstraZeneca-Oxford University Partnered Nasal COVID-19 Vaccine Flunks Human Trial October 11, 2022 AstraZeneca Plc (NASDAQ: AZN) and Oxford University scientists said that the initial testing of its nasal COVID-19 vaccine did not yield the desired protection. Via Benzinga Why Are LogicBio Therapeutics Shares Skyrocketing Today? October 03, 2022 Via Benzinga How To Invest In UK Market Turmoil October 02, 2022 With investors speculating about what steps the central bank might take, it’s clear that the UK’s turbulence is far from over. So, let’s take a look at the market winners and losers that are likely to... Via Talk Markets < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.